On May 7, 2020 Halozyme Therapeutics, Inc. (NASDAQ: HALO), reported that it will participate in the Bank of America Securities 2020 Healthcare Conference (Press release, Halozyme, MAY 7, 2020, View Source [SID1234557325]. This conference is being hosted virtually . Dr. Helen Torley, president and chief executive officer, will provide an overview of the company on Thursday, May 14 at 5:00 p.m. ET / 2:00 p.m. PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation can be accessed through the "Investors" section of www.halozyme.com, and a recording will be made available for 90 days following each event. To access a live webcast, please visit Halozyme’s website approximately 15 minutes prior to the presentation to register and download any necessary audio software.